Is zidovudine first‐line therapy virologically comparable to tenofovir in resource‐limited settings?

E-ISSN： 1365-3156|20|7|914-918

ISSN： 1360-2276

Source： TROPICAL MEDICINE & INTERNATIONAL HEALTH, Vol.20, Iss.7, 2015-07, pp. : 914-918

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance

JOURNAL OF MEDICAL VIROLOGY, Vol. 90, Iss. 3, 2018-03 ,pp. : 497-502

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison between merthiolate–iodine–formalin and Kato–Katz methods for the diagnosis of human helminth infections in resource-limited settings

Journal of Helminthology, Vol. 91, Iss. 6, 2017-11 ,pp. : 657-664

Cambridge University Press

Access to resources Recommend Favorite

Is Resistance to Dolutegravir Possible When This Drug Is Used in First-Line Therapy?

By Mesplède Thibault Wainberg Mark A.

Viruses, Vol. 6, Iss. 9, 2014-08 ,pp. : 3377-3385

MDPI

Access to resources Recommend Favorite

High Levels of Dual-Class Drug Resistance in HIV-Infected Children Failing First-Line Antiretroviral Therapy in Southern Ethiopia

By Tadesse Birkneh Tilahun Kinloch Natalie N. Baraki Bemuluyigza Lapointe Hope R. Cobarrubias Kyle D. Brockman Mark A. Brumme Chanson J. Foster Byron A. Jerene Degu Makonnen Eyasu Aklillu Eleni Brumme Zabrina L.

Viruses, Vol. 10, Iss. 2, 2018-02 ,pp. : 60-60

MDPI

Access to resources Recommend Favorite

Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first‐line combination antiretroviral therapy

HIV MEDICINE, Vol. 16, Iss. 9, 2015-10 ,pp. : 553-562

John Wiley & Sons Inc

Access to resources Recommend Favorite